```html

Quantitative Blood Loss

What is Quantitative Blood Loss?

Quantitative blood loss (QBL) refers to the measurable amount of blood that a person loses over a given period of time. Unlike vague descriptions such as “heavy bleeding,” QBL is expressed in units of volume (milliliters or ounces) and can be objectively tracked using calibrated devices, weighing of soaked dressings, or laboratory testing (e.g., hemoglobin/hematocrit levels). Accurate measurement is crucial in many settings—including surgery, obstetrics, trauma, and chronic medical conditions—because it guides decisions about fluid replacement, transfusion, and further investigations.

In everyday language, “quantitative blood loss” may be used to describe any discernible, numerically‑estimated bleeding episode, whether it occurs externally (e.g., menstrual or gastrointestinal bleeding) or internally (e.g., internal organ rupture). The underlying principle is the same: a proven loss of blood that is large enough to affect the body’s oxygen‑carrying capacity and overall health.

Common Causes

Several medical conditions and situations can lead to a measurable loss of blood. Below are ten of the most frequent causes:

• Trauma: blunt or penetrating injuries (e.g., car accidents, falls, stab wounds) cause rapid external or internal bleeding.
• Surgical procedures: operative blood loss is expected, but excessive intra‑operative bleeding may signal a coagulopathy or technical issue.
• Obstetric events: postpartum hemorrhage, placental abruption, or uterine atony often result in >500 mL (vaginal) or >1000 mL (cesarean) blood loss.
• Gastrointestinal (GI) bleeding: peptic ulcers, diverticulosis, colorectal cancer, or inflammatory bowel disease can produce measurable melena or hematochezia.
• Gynecologic bleeding: heavy menstrual bleeding (menorrhagia), uterine fibroids, or hormonal disorders.
• Hemorrhagic disorders: hemophilia, von Willebrand disease, or acquired coagulopathies (e.g., liver disease, vitamin K deficiency).
• Anticoagulant/antiplatelet therapy: warfarin, direct oral anticoagulants (DOACs), aspirin, or clopidogrel increase bleeding risk, especially after injury.
• Vascular anomalies: aneurysms, arteriovenous malformations, or hereditary hemorrhagic telangiectasia can bleed spontaneously.
• Severe infections: disseminated intravascular coagulation (DIC) from sepsis or meningococcemia leads to widespread bleeding.
• Neoplasms: tumors of the liver, spleen, or bone marrow can erode vessels, causing chronic occult bleeding.

Associated Symptoms

Quantitative blood loss seldom occurs in isolation. Commonly accompanying signs and symptoms include:

• Fatigue, weakness, or dizziness—reflecting reduced oxygen delivery.
• Shortness of breath, especially on exertion.
• Pale or “ashen” skin and mucous membranes.
• Rapid heart rate (tachycardia) and low blood pressure (hypotension).
• Cold, clammy extremities.
• Chest pain or angina in patients with underlying heart disease.
• Headache, confusion, or fainting (syncope) when cerebral perfusion drops.
• Bleeding‐related signs specific to the source, such as:
  • Bright red vaginal bleeding (menorrhagia).
  • Black, tarry stools (melena) from upper GI bleed.
  • Bright red blood per rectum (hematochezia) from lower GI bleed.
  • Bruising, petechiae, or easy bruising when a clotting disorder is present.

When to See a Doctor

Even modest blood loss can become serious if it continues unchecked. Seek professional care promptly if you experience any of the following:

• Bleeding that soaks through a standard sanitary pad or more than one pad per hour.
• More than 80 mL of blood loss in a single episode (e.g., after a minor injury or during menstruation).
• Persistent vaginal bleeding lasting longer than 7 days or requiring a change of protection every hour.
• Vomiting blood, black/tarry stools, or bright red blood per rectum.
• Rapid heart rate (>100 bpm), light‑headedness, or fainting.
• Sudden swelling, pain, or tightness in the abdomen or chest.
• Any bleeding while on anticoagulant therapy that seems out of proportion to the injury.
• Worsening fatigue, shortness of breath, or difficulty performing routine activities.

Diagnosis

Evaluating quantitative blood loss blends quantitative measurement with a systematic search for the underlying cause.

Initial Assessment

• Vital signs: blood pressure, heart rate, respiratory rate, oxygen saturation.
• Physical examination: inspection of wounds, abdomen, pelvis, and skin for bruising or petechiae.
• Estimation of volume:
  • Weight of soaked dressings (1 g ≈ 1 mL of blood).
  • Calibrated suction canisters in surgical settings.
  • Visual analog scales for menstrual blood (e.g., >80 mL = >1 heavy pad/hour).

Laboratory Tests

• Complete blood count (CBC) – hemoglobin/hematocrit to gauge anemia.
• Coagulation profile – PT/INR, aPTT, fibrinogen, D‑dimer.
• Blood type & cross‑match – in case transfusion is needed.
• Renal and liver function panels – to assess organ contribution to coagulopathy.
• Specific tests for GI bleed: fecal occult blood, stool guaiac, or upper endoscopy labs.

Imaging & Specialized Studies

• Focused ultrasound (FAST) for intra‑abdominal bleeding after trauma.
• CT angiography to locate active hemorrhage (e.g., from organ injury or aneurysm).
• Transvaginal ultrasound for obstetric hemorrhage or uterine pathology.
• Endoscopy (esophagogastroduodenoscopy or colonoscopy) for gastrointestinal sources.
• Bone marrow biopsy when chronic occult bleeding suggests a hematologic malignancy.

Treatment Options

Management is directed at two goals: stop the bleeding and restore circulating blood volume.

Immediate Measures

• Apply direct pressure: for external wounds, use sterile gauze and firm, sustained pressure.
• Tourniquet: only for severe limb bleeding when pressure fails (as per STOP THE BLEED® guidelines).
• Uterine massage or balloon tamponade: in postpartum hemorrhage.
• IV fluid resuscitation: isotonic crystalloids (normal saline or lactated Ringer’s) to maintain perfusion.
• Tranexamic acid (TXA): 1 g IV over 10 min followed by 1 g over 8 h; shown to reduce mortality in trauma and postpartum hemorrhage (CRASH‑2 & WOMAN trials).

Blood Product Replacement

• Packed red blood cells (PRBC): indicated when hemoglobin < 7 g/dL (or < 8 g/dL in symptomatic patients).
• Fresh frozen plasma (FFP) and platelets: for coagulopathy or thrombocytopenia.
• Whole blood: increasingly used in massive transfusion protocols.

Definitive Treatment of the Underlying Cause

• Surgical repair (e.g., laparotomy for intra‑abdominal bleed, hysterectomy for uncontrolled uterine bleeding).
• Endoscopic therapy (injection, coagulation, or clipping of GI lesions).
• Medication adjustments—holding or reversing anticoagulants (vitamin K, idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors).
• Hormonal therapy for menorrhagia (combined oral contraceptives, levonorgestrel IUD, or tranexamic acid).
• Management of chronic diseases (e.g., treating ulcer disease with proton‑pump inhibitors, controlling liver disease).

Home & Supportive Care

• Iron supplementation (oral ferrous sulfate 325 mg 1–3×/day) after acute bleeding to replenish stores.
• Diet rich in iron (red meat, beans, leafy greens) and vitamin C to aid absorption.
• Monitoring for recurrent bleeding—keep a diary of pads, dressings, or stool color.
• Follow‑up appointments for repeat CBCs and imaging as recommended.

Prevention Tips

While some bleeding events cannot be avoided, many strategies reduce risk:

• Take anticoagulants exactly as prescribed; discuss dose adjustments before surgeries or dental work.
• Use protective gear (helmets, pads) during high‑risk activities.
• Maintain a healthy liver (limit alcohol, avoid hepatotoxic drugs) to preserve clotting factor production.
• Control chronic conditions—manage hypertension, diabetes, and ulcer disease to prevent vessel fragility.
• Screen for and treat anemia or iron deficiency early, especially in women with heavy menstrual periods.
• For women with known fibroids or endometrial pathology, consider regular gynecologic follow‑up and discuss hormonal or surgical options.
• Educate family members on basic bleeding control (direct pressure, tourniquet) using programs like “STOP THE BLEED.”
• Stay up‑to‑date on vaccinations (e.g., Hepatitis B) to prevent liver disease that can impair clotting.

Emergency Warning Signs

• Sudden loss of consciousness or fainting.
• Rapid, weak pulse with systolic blood pressure < 90 mm Hg (shock).
• Chest pain or shortness of breath that worsens rapidly.
• Severe abdominal or pelvic pain with signs of distension.
• Bleeding that fills a dressing in less than 5 minutes or cannot be stopped with pressure.
• Vomiting large amounts of bright red blood or coffee‑ground material.
• Heavy vaginal bleeding that soaks through more than one pad per hour for >2 hours.
• Visible signs of internal bleeding: bruising around the abdomen, flank, or back (Grey‑Turner sign).
• Any bleeding while on anticoagulant therapy that seems out of proportion to the injury.
• Severe headache, vision changes, or seizures indicating intracranial hemorrhage.

These red‑flag symptoms demand immediate emergency medical care—call 911 or go to the nearest emergency department.

---

References:

• American College of Surgeons. ATLS®: Advanced Trauma Life Support, 10th ed., 2023.
• Mayo Clinic. “Postpartum hemorrhage.” Updated 2024.
• World Health Organization. “Maternal health: Postpartum hemorrhage.” 2022.
• NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Upper GI bleeding.” 2023.
• Cleveland Clinic. “Tranexamic acid (TXA) in trauma and obstetric bleeding.” 2023.
• STOP THE BLEED® Initiative, American College of Surgeons, 2022.

```